Bandhan BSE Healthcare Index Fund - Regular Plan - Growth
Bandhan Asset Management Company Limited
₹11.09 (+0.66%)
NAV as of 9 Oct 2026
Minimum Investment: ₹1,000
Return
9.61% Returns for 1Y
Expense ratio & Others
- Net expense ratio
- 1.02%
- Exit load
- 0%
- Lock-in
- No
- Minimum investment
- ₹1,000
- Category
- Index Funds
Expense ratio is inclusive of GST. Returns may be taxed based on the fund type and your holding period — please read the scheme-related documents and consult a tax advisor. Figures are historical and do not guarantee future results.
Fund Returns Estimator
One-time investment
₹1,000
6 months
₹1,148
Invested ₹1,000
▲+14.83%1 year
₹1,096
Invested ₹1,000
▲+9.61%
Based on the fund’s historic trailing returns — a planning illustration, not a guarantee of future results.
Invest One-TimePlan it your way
The figures above are fixed to this fund’s past returns over set periods. Use a calculator to set your own amount, tenure and expected rate of return.
Risk level
Riskometer scale
- Low
- Low to Moderate
- Moderate
- Moderate to High
- High
- Very HighThis fund
Riskometer level assigned by the fund house as per SEBI norms. It can change as the scheme’s portfolio changes.
Fund benchmark
| Primary Index Name | — |
|---|---|
| Secondary Index Name | — |
| Index Name | BSE Healthcare TR INR |
| Weighting | 100% |
Returns
| 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|
| Fund returns (%) | +9.61% | — | — | — |
| Cumulative returns (%) | +9.61% | — | — | — |
Fund Manager
| Manager | Mayuresh Nagvekar |
|---|---|
| Role | Manager |
| Manager Tenure | 0.62 yrs |
About Fund
| Date of Incorporation | 22 Oct 2024 |
|---|---|
| Fund House | Bandhan Asset Management Company Limited |
| Custodian | Deutsche Bank AG |
| Registrar / Transfer Agent | Bandhan Asset Management Company Limited |
| Address | 1 Great Winchester Street |
Top Holdings
| Company | Weightage (%) |
|---|---|
| Sun Pharmaceuticals Industries Ltd | 12.95% |
| Divi's Laboratories Ltd | 7.22% |
| Apollo Hospitals Enterprise Ltd | 5.55% |
| Cipla Ltd | 4.91% |
| Max Healthcare Institute Ltd Ordinary Shares | 4.62% |
| Laurus Labs Ltd | 4.48% |
| Torrent Pharmaceuticals Ltd | 4.36% |
| Dr Reddy's Laboratories Ltd | 4.35% |
| Lupin Ltd | 3.24% |
| Fortis Healthcare Ltd | 2.90% |
Investment Strategy
The investment objective of the Scheme is to replicate the BSE Healthcare Index by investing in securities of the BSE Healthcare Index in the same proportion / weightage with an aim to provide returns before expenses that track the total return of BSE Healthcare Index, subject to tracking errors.
To create wealth over a long term
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully. The data shown is for information only and does not constitute investment advice.